Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

NCT00514020 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin
GENETIC: gene expression analysis
GENETIC: polymorphism analysis
GENETIC: protein expression analysis
OTHER: pharmacological study

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]